PREGNIDOXIN NU TABLET

Manufacturer :
Composition : DOXYLAMINE-10MG+PYRIDOXINE (VITB6)-10MG
Dose Form : TABLET
Description : PREGNIDOXIN NU TAB
Route Of Administration : ORAL
Pack : 10
Out of stock
SKU
PRE0688
₹53.75
Manufacturer :
Composition : DOXYLAMINE-10MG+PYRIDOXINE (VITB6)-10MG
Dose Form : TABLET
Description : PREGNIDOXIN NU TAB
Route Of Administration : ORAL
Pack : 10

Drug Ingredient Information

DOXYLAMINE-10MG+PYRIDOXINE (VITB6)-10MG

DOXYLAMINE

Information for patients
Drug Information Insomnia Self-medication for short-term management of insomnia,a particularly in individuals who have difficulty falling asleep.102 Safety and efficacy not fully established; however, FDA states that, pending further accumulation of data, doxylamine-containing nighttime sleep aids that have been approved for this use may continue to be marketed in the US. Allergic Rhinitis Temporary relief of rhinorrhea, sneezing, lacrimation, itching eyes, or oronasopharyngeal itching associated with allergic rhinitis (e.g., hay fever) or other upper respiratory allergies
Drug Alert
Alert no data available
Before Consuming the Medicine
Avoid Drug no data available
Drug Special Care Concomitant Diseases Because of possible anticholinergic effects (e.g., dryness of mouth, nose, and throat; dysuria; urinary retention),b patients with glaucoma, respiratory conditions (e.g., emphysema, chronic bronchitis), or difficulty urinating due to prostatic hypertrophy should consult a clinician before initiating therapy with doxylamine.101 102 Use with caution, if at all, in patients with angle-closure glaucoma, prostatic hypertrophy, stenosing peptic ulcer, pyloroduodenal obstruction, or bladder neck obstruction.b Use not recommended, unless under the direction of a clinician, in patients who have a breathing problem (e.g., emphysema, chronic bronchitis). Use generally not recommended in asthmatics who previously experienced a serious antihistamine-induced adverse bronchopulmonary effect. CNS Effects Risk of marked drowsiness.101 Caution when driving a motor vehicle or operating machinery.101 (See CNS Depressants under Interactions and also see Advice to Patients.) Possible excitability (especially in children).101 b (See Pediatric Use under Cautions.) Sensitivity Reactions Tartrazine Sensitivity Some commercially available preparations (e.g., Aldex AN oral suspension) may contain the dye tartrazine (FD&C yellow No. 5); possible allergic reactions in susceptible individuals (e.g., those sensitive to aspirin)
Drug Drug Interactions no data available
Drug Pregnancy Interaction Women considering self-medication with doxylamine during pregnancy should consult a health professional for advice regarding the relative risks and benefits of such therapy.
Drug Breast feeding Interaction Expected to be distributed into milk.103 Discontinue nursing or the drug.
Drug Machinery Interaction no data available
Drug More Information no data available
How to take the Medicine
Consumption Info no data available
Drug quanitty Administration Oral Administration Administer orally as tablets or oral suspension.101 102 a Dosage Available as doxylamine succinate; dosage expressed in terms of the salt.101 102 Individualize dosage according to patient’s response and tolerance.b Pediatric Patients Insomnia Oral Self-medication in children =12 years of age: 25 mg 30 minutes before retiring or as directed by a clinician.102 Allergic Rhinitis Children 2 to <6 years of age: 1.9–3.125 mg every 4–6 hours, not to exceed 18.75 mg in 24 hours. Children 6 to <12 years of age: For self-medication, 3.75–6.25 mg every 4–6 hours, not to exceed 37.5 mg in 24 hours. Alternatively, under the direction of a clinician, up to 12.5 mg every 4–6 hours, or 2 mg/kg or 60 mg/m2 daily in divided doses, not to exceed 75 mg daily. Children =12 years of age: For self-medication, 7.5–12.5 mg every 4–6 hours, not to exceed 75 mg in 24 hours. Alternatively, under the direction of a clinician, up to 25 mg every 4–6 hours, or 2 mg/kg or 60 mg/m2 daily in divided doses, not to exceed 150 mg daily. Adults Insomnia Oral Self-medication: 25 mg 30 minutes before retiring or as directed by a clinician.102 Allergic Rhinitis Oral Self-medication: 7.5–12.5 mg every 4–6 hours, not to exceed 75 mg in 24 hours. Alternatively, under the direction of a clinician, up to 25 mg every 4–6 hours, or 2 mg/kg or 60 mg/m2 daily in divided doses, not to exceed 150 mg daily. Prescribing Limits Pediatric Patients Insomnia Oral Self-medication in children =12 years of age: Maximum 2 weeks.102 Allergic Rhinitis Oral Children 2 to <6 years of age: Maximum 18.75 mg in 24 hours. Children 6 to <12 years of age: For self-medication, maximum 37.5 mg in 24 hours. Under the direction of a clinician, maximum 75 mg daily. Children =12 years of age: For self-medication, maximum 75 mg in 24 hours. Under the direction of a clinician, maximum 150 mg daily. Adults Insomnia Oral Self-medication: Maximum 2 weeks.102 Allergic Rhinitis Oral For self-medication, maximum 75 mg in 24 hours. Under the direction of a clinician, maximum 150 mg daily.
Drug Dose no data available
Excess Drug Consumption Dail 1066. OR Contact doctor immediately
Forgot Drug Consumption Contact Your doctor
Stop Drug Consumption Do not stop the drug untill your doctor says you to do so.
Possible Side Effects
General Information no data available
Common Drug Side Effects no data available
Rare Drug Side Effects no data available
Very Rare Drug Side Effects no data available
Drug Side Effects Symptoms no data available
How to Store the Medicine
How to Store the Medicine Store in a cool and dry place.

PYRIDOXINE (VITB6)

Information for patients
Drug Information Pyridoxine (also called pyridoxol)[2] is one form of vitamin B6. Its hydrochloride salt, pyridoxine hydrochloride, is used as a vitamin B6 dietary supplement.
Drug Alert
Alert no data
Before Consuming the Medicine
Avoid Drug no data
Drug Special Care Should be taken with food. Preferably taken w/ meals.
Drug Drug Interactions Isoniazid, penicillamine and oral contraceptives may result in greater requirement in pyridoxine dose. Reduces the effects of levodopa, phenobarbitone, altretamine and phenytoin.
Drug Pregnancy Interaction Category A: Controlled studies in women fail to demonstrate a risk to the foetus in the 1st trimester (and there is no evidence of a risk in later trimesters), and the possibility of foetal harm remains remote.
Drug Breast feeding Interaction no data
Drug Machinery Interaction no data
Drug More Information no data
How to take the Medicine
Consumption Info
Drug quanitty Oral Treatment and prophylaxis of vitamin B<209>6<190> deficiency states Adult: Up to 150 mg daily. May also be given via SC, IM or IV routes. Oral Sideroblastic anaemia Adult: Up to 400 mg daily
Drug Dose no data
Excess Drug Consumption Severe peripheral neuropathies (with long-term admin of large doses).
Forgot Drug Consumption no data
Stop Drug Consumption Symptoms of dependence have been noted in adults given only 200 mg daily, followed by withdrawal.
Possible Side Effects
General Information no data
Common Drug Side Effects Clumsiness numbness of hands or feet
Rare Drug Side Effects no data
Very Rare Drug Side Effects no data
Drug Side Effects Symptoms no data
How to Store the Medicine
How to Store the Medicine

Substitute Drugs

Write Your Own Review
You're reviewing:PREGNIDOXIN NU TABLET
Your Rating

Get Captcha Image